Nuvalent (NUVL) Stock Forecast & Price Target

$66.86
+0.79 (+1.20%)
(As of 04/26/2024 ET)

Nuvalent Consensus Analyst Rating and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analysts' Consensus Rating

Moderate Buy
Based on 10 Analyst Ratings

Analysts' Consensus Price Target

$90.78
35.77% Upside
High Forecast$110.00
Average Forecast$90.78
Low Forecast$42.00
TypeCurrent Forecast
4/28/23 to 4/27/24
1 Month Ago
3/29/23 to 3/28/24
3 Months Ago
1/28/23 to 1/28/24
1 Year Ago
4/28/22 to 4/28/23
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
9 Buy rating(s)
6 Buy rating(s)
5 Buy rating(s)
2 Buy rating(s)
Hold
1 Hold rating(s)
3 Hold rating(s)
3 Hold rating(s)
0 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$90.78$81.50$62.00$44.50
Predicted Upside35.77% Upside12.36% Upside20.15% Upside24.41% Upside
Get Nuvalent Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for NUVL and its competitors with MarketBeat's FREE daily newsletter.

NUVL Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

NUVL Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Nuvalent Stock vs. The Competition

TypeNuvalentMedical CompaniesS&P 500
Consensus Rating Score
2.90
2.68
2.49
Consensus RatingModerate BuyModerate BuyHold
Predicted Upside35.77% Upside3,089.33% Upside10.52% Upside
News Sentiment RatingPositive News
Neutral News
Positive News

Recent Analyst Ratings and Stock Forecasts

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
4/17/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$97.00+50.48%
4/1/2024Leerink Partnrs
Subscribe to MarketBeat All Access for the recommendation accuracy rating
A. Berens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeMarket Perform ➝ Outperform
4/1/2024SVB Leerink
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeMarket Perform ➝ Outperform$69.00 ➝ $110.00+46.49%
3/6/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$68.00 ➝ $98.00+16.43%
2/28/2024BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$93.00 ➝ $102.00+15.45%
2/28/2024Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$99.00+11.25%
2/27/2024Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOutperform$99.00+11.25%
2/23/2024Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform$105.00+26.16%
10/4/2023Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy
8/8/2023SVB Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageMarket Perform$42.00-5.87%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 02:25 AM ET.

NUVL Price Target - Frequently Asked Questions

What is Nuvalent's consensus rating and price target?

According to the issued ratings of 10 analysts in the last year, the consensus rating for Nuvalent stock is Moderate Buy based on the current 1 hold rating and 9 buy ratings for NUVL. The average twelve-month price prediction for Nuvalent is $90.78 with a high price target of $110.00 and a low price target of $42.00. Learn more on NUVL's analyst rating history.

Do Wall Street analysts like Nuvalent more than its competitors?

Analysts like Nuvalent more than other Medical companies. The consensus rating score for Nuvalent is 2.90 while the average consensus rating score for medical companies is 2.68. Learn more on how NUVL compares to other companies.

Is Nuvalent being upgraded by Wall Street analysts?

Over the previous 90 days, Nuvalent's stock had 2 upgrades by analysts.

Does Nuvalent's stock price have much upside?

According to analysts, Nuvalent's stock has a predicted upside of 20.76% based on their 12-month stock forecasts.

What analysts cover Nuvalent?

Stock Ratings Reports and Tools

This page (NASDAQ:NUVL) was last updated on 4/27/2024 by MarketBeat.com Staff

From Our Partners